Your browser doesn't support javascript.
loading
A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins.
Barwicz, J; Gruda, I; Tancrède, P.
Afiliación
  • Barwicz J; Département de Chimie-Biologie, Université du Québec à Trois-Rivières, P.O. Box 500, Trois-Rivières, Que., Canada.
FEBS Lett ; 465(1): 83-6, 2000 Jan 07.
Article en En | MEDLINE | ID: mdl-10620711
The UV-visible results of this kinetic study show that amphothericin B as Fungizone is a much stronger oxidant than CuSO(4), itself a powerful oxidant of low-density lipoprotein (LDL). Amphotericin B as AmBisome alone has no oxidizing effect on LDL while a mixture of both AmBisome and CuSO(4) induces an important potentialization of the LDL oxidation. These results allow us to believe that the high toxicity of amphotericin B is related to its capacity to modify and to weaken the structure of LDL. In addition, differential scanning calorimetry experiments show that the oxidative modifications of LDL by CuSO(4) or by amphotericin B proceed through different mechanisms.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anfotericina B / Lipoproteínas LDL Límite: Humans Idioma: En Revista: FEBS Lett Año: 2000 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anfotericina B / Lipoproteínas LDL Límite: Humans Idioma: En Revista: FEBS Lett Año: 2000 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido